Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

First China Approved Rituximab Biosimilar HLX01: Pharmacokinetics, Safety and Efficacy Comparison to Reference Rituximab in the Phase 3 Diffuse Large B-Cell Lymphoma Study

Blood (2019) 134 (Supplement_1): 2878.

https://doi.org/10.1182/blood-2019-130603

Published: 2019

Journal Articles

Clinical and Quality of Life Predictors of Failure to Achieve Event Free Survival at 24 Months in Patients Aged 70 Years and Older with Diffuse Large B-Cell Lymphoma

Patrick M. Reagan, MD, Andrea M Baran, MS, Matthew J. Maurer, MS, Andrew L. Feldman, MD, Thomas M. Habermann, MD, Susan L. Slager, PhD, Gita Thanarajasingam, MD, Kathleen J Yost, PhD, Brian K. Link, MD, James R. Cerhan, MD PhD, Carrie A. Thompson, MD

Blood (2018) 132 (Supplement 1): 3579.

https://doi.org/10.1182/blood-2018-99-118356

Published: 2018

Journal Articles

CAN WE Predict Risk Factors of Venous Thromboembolism Among Cancer Inpatients?

Shiva Shrotriya, MD MPH, Prajwal Dhakal, MBBS, Mukta Sharma, MBBS, Joseph Gardiner, Anas Al-Janadi, MD, Alex Lupi, Ahmad Delshad, Supratik Rayamajhi, MD

Blood (2018) 132 (Supplement 1): 5871.

https://doi.org/10.1182/blood-2018-99-119698

Published: 2018

Journal Articles

What Predicts Venous Thromboembolism Among Cancer Inpatients: A Proposed Predictive Model

Shiva Shrotriya, MBBS, Prajwal Dhakal, MBBS, Mukta Sharma, MBBS, Joseph Gardiner, Alexa Lupi, MS, Supratik Rayamajhi, MD

Blood (2017) 130 (Supplement 1): 3708.

https://doi.org/10.1182/blood.V130.Suppl_1.3708.3708

Published: 2017

Journal Articles

Low Peripheral Blood NK Cell Count Is Associated with Worse Clinical Outcome in Patients with Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results from the Frontline Phase 3 GALLIUM and GOYA Trials

Magdalena Klanova, MD, Mikkel Z. Oestergaard, Marek Trněný, MD PhD, Wolfgang Hiddemann, MD PhD, Robert Marcus, Laurie H. Sehn, MDMPH, Umberto Vitolo, MD, Alexandra Bazeos, Valentin Goede, MD, Harald Zeuner, Andrea Knapp, Denis Sahin, Nathalie Danesi, Christopher Bolen, Susan Robson, Jeffrey M. Venstrom, Tina Nielsen, Günter Fingerle-Rowson

Blood (2017) 130 (Supplement 1): 727.

https://doi.org/10.1182/blood.V130.Suppl_1.727.727

Published: 2017

Journal Articles

Multivariate Efficacy Analysis of a Randomized, Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Treatment-Related Acute Myeloid Leukemia (AML) or AML with Myelodysplasia-Related Changes

Geoffrey L. Uy, MD, Jeffrey E. Lancet, MD, Jorge E. Cortes, MD, Laura F. Newell, MD, Tara L. Lin, MD, Ellen K Ritchie, MD, Robert K. Stuart, MD, Stephen A Strickland, Donna Hogge, Scott R Solomon, MD, Richard M. Stone, MD, Dale L. Bixby, Jonathan E. Kolitz, MD, Gary J. Schiller, Matthew J. Wieduwilt, Lynn Shemanski, Michael Chiarella, Arthur C Louie, Bruno C Medeiros, MD

Blood (2017) 130 (Supplement 1): 2647.

https://doi.org/10.1182/blood.V130.Suppl_1.2647.2647

Published: 2017

Journal Articles

Population Pharmacokinetic Modeling of Intravenous Asparaginase Erwinia Chrysanthemi : Impact of Varied Infusion Rates on Exposure

Katie Zomorodi, PhD, Todd Dumas, PharmD, Seth Berry, PharmD, Curtis Johnston, PharmD, Mark Eller, PhD

Blood (2016) 128 (22): 1631.

https://doi.org/10.1182/blood.V128.22.1631.1631

Published: 2016

Journal Articles

Identification and Validation of Novel Hematopoietic Stem Cell Regulatory microRNAs

Elias Simon Peter Eckert, Peer Wünsche, Manfred Schmidt, PhD, Claudia Ball, PhD, Friederike Herbst, PhD, Hanno Glimm

Blood (2016) 128 (22): 3872.

https://doi.org/10.1182/blood.V128.22.3872.3872

Published: 2016

Journal Articles

Atherosclerotic Cardiovascular Risk in Adult Patients with Hemophilia: What We Can Do to Reduce Risk of Cardiovascular Events? Implementation of 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol in Patients with Hemophilia

Kamila Izabela Cisak, MD, Jianmin Pan, PhD, Shesh Nath Rai, PhD, Patricia Ashby, ARNP, Vivek R. Sharma, MD FACP

Blood (2015) 126 (23): 4687.

https://doi.org/10.1182/blood.V126.23.4687.4687

Published: 2015

Journal Articles

Prevalence of Hypertension, Diabetes, Obesity and Smoking in Patients with Hemophilia Followed at a Single Treatment Center

Kamila Izabela Cisak, MD, Jianmin Pan, PhD, Shesh Nath Rai, PhD, Patricia Ashby, ARNP, Vivek R. Sharma, MD FACP

Blood (2015) 126 (23): 4692.

https://doi.org/10.1182/blood.V126.23.4692.4692

Published: 2015

Journal Articles

What Is the Most Cost-Effective Strategy for Treating Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia (CML) after Imatinib Loses Patent Exclusivity?

Richard A. Larson, Rena Conti, PhD, William V. Padula, PhD, Jane F. Apperley, Michele Baccarani, MD, Ekkehard Eigendorff, MD, Francois Guilhot, MD, Joelle Guilhot, PhD, Francois-Xavier Mahon, MD PhD, Giovanni Martinelli, MD, Jiri Mayer, Prof., MD PhD, Martin C. Mueller, Dietger Niederwieser, MD, Susanne Saussele, MD, Charles A. Schiffer, MD, Richard T. Silver, MD, Bengt Simonsson, MD PhD, Rudiger Hehlmann, MD

Blood (2014) 124 (21): 738.

https://doi.org/10.1182/blood.V124.21.738.738

Published: 2014

Journal Articles

Selective Splenic Artery Embolization for the Treatment of Thrombocytopenia and Hypersplenism in Paroxysmal Nocturnal Hemoglobinuria (PNH)

Anna Paola Iori, Karen Brown, David J. Araten, Emilia Scalzulli, Giovanni Fernando Torelli, Maria Stefania De Propris, Corrado Girmenia, Filippo Maria Salvatori, Orly Zelig, Robin Foa, MD, Lucio Luzzatto

Blood (2012) 120 (21): 4408.

https://doi.org/10.1182/blood.V120.21.4408.4408

Published: 2012

Journal Articles

Diagnostic Challenge Presented by “Hb F only” Pattern In Newborn Screening for Hemoglobinopathies: Approach to Accurate Diagnosis

Niren Patel, MBBS, Hanfang Zhang, MD, PhD, Lina Zhuang, MD, Rupa Redding-Lallinger, MD, Ruth Luddy, MD, Abdullah Kutlar, MD, Ferdane Kutlar, MD

Blood (2010) 116 (21): 5173.

https://doi.org/10.1182/blood.V116.21.5173.5173

Published: 2010

Journal Articles

Population Pharmacokinetics of Alemtuzumab in Patients with Hematologic Malignancies.

Peter L. Bonate, Michael Keating, Steve Weitman, Peter Hillmen, Diane R. Mould

Blood (2005) 106 (11): 2961.

https://doi.org/10.1182/blood.V106.11.2961.2961

Published: 2005

Journal Articles

Identification of a Set of Seven Genes for the Monitoring of Minimal Residual Disease in Pediatric Acute Myeloid Leukemia.

Daniel Steinbach, MD, Alexander Schramm, PhD, Angelika Eggert, MD, Susann Wittig, Nadine Pfaffendorf, Astrid Voigt, PhD, Felix Zintl, MD, Bernd Gruhn, MD

Blood (2005) 106 (11): 1461.

https://doi.org/10.1182/blood.V106.11.1461.1461

Published: 2005

NARROW

First China Approved Rituximab Biosimilar HLX01: Pharmacokinetics, Safety and Efficacy Comparison to Reference Rituximab in the Phase 3 Diffuse Large B-Cell Lymphoma Study

Clinical and Quality of Life Predictors of Failure to Achieve Event Free Survival at 24 Months in Patients Aged 70 Years and Older with Diffuse Large B-Cell Lymphoma

CAN WE Predict Risk Factors of Venous Thromboembolism Among Cancer Inpatients?

What Predicts Venous Thromboembolism Among Cancer Inpatients: A Proposed Predictive Model

Low Peripheral Blood NK Cell Count Is Associated with Worse Clinical Outcome in Patients with Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Immunochemotherapy: Results from the Frontline Phase 3 GALLIUM and GOYA Trials

Multivariate Efficacy Analysis of a Randomized, Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Treatment-Related Acute Myeloid Leukemia (AML) or AML with Myelodysplasia-Related Changes

Population Pharmacokinetic Modeling of Intravenous Asparaginase Erwinia Chrysanthemi : Impact of Varied Infusion Rates on Exposure

Identification and Validation of Novel Hematopoietic Stem Cell Regulatory microRNAs

Atherosclerotic Cardiovascular Risk in Adult Patients with Hemophilia: What We Can Do to Reduce Risk of Cardiovascular Events? Implementation of 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol in Patients with Hemophilia

Prevalence of Hypertension, Diabetes, Obesity and Smoking in Patients with Hemophilia Followed at a Single Treatment Center

What Is the Most Cost-Effective Strategy for Treating Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia (CML) after Imatinib Loses Patent Exclusivity?

Selective Splenic Artery Embolization for the Treatment of Thrombocytopenia and Hypersplenism in Paroxysmal Nocturnal Hemoglobinuria (PNH)

Diagnostic Challenge Presented by “Hb F only” Pattern In Newborn Screening for Hemoglobinopathies: Approach to Accurate Diagnosis

Population Pharmacokinetics of Alemtuzumab in Patients with Hematologic Malignancies.

Identification of a Set of Seven Genes for the Monitoring of Minimal Residual Disease in Pediatric Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only